ALLISON HARWOOD: Open Payments
NPI 1689309312 · WINSTON SALEM, NC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$529 in 19 payments from 10 companies in 2025. Trend: 2023 $175 · 2024 $209 · 2025 $529
Food & beverage: $429Education: $100
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 3 | $136 |
| UCB, Inc. | 4 | $124 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 2 | $57 |
| ABBVIE INC. | 2 | $49 |
| Lilly USA, LLC | 2 | $36 |
| GENZYME CORPORATION | 1 | $34 |
| Galderma Laboratories, L.P. | 2 | $34 |
| Amgen Inc. | 1 | $24 |
| Arcutis Biotherapeutics, Inc. | 1 | $18 |
| Novartis Pharmaceuticals Corporation | 1 | $17 |
Products named: TREMFYA, Bimzelx, ILUMYA, MOUNJARO, DUPIXENT, NEMLUVIO, RINVOQ, OTEZLA.
Industry payments across NC — which companies pay providers there.
